Atlas Trials

Precision Treatment of Unresectable HCC Guided by Multi-omics Deep Learning Models

Clinical trial NCT06463444 · UNKNOWN

Trial details

NCT number
NCT06463444
Sponsor
Chen Xiaoping
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
HCCPrecision Therapy
Start date
2024-06-01
Primary completion
2025-06-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.